1st Annual International Congress on the Future of Neurology™


1st Annual International Congress on the Future of Neurology™

September 27-28, 2019
InterContinental New York Times Square

300 West 44th Street
New York, NY 10036

Book Online: IFN 19 - Reservations

Overview


There continues to be significant progress in the development of novel therapeutics in the treatment of many neurologic disorders. With the emergence of these new therapeutic strategies, and a robust pipeline of novel agents, we now have more treatment options that can improve outcomes in your patients in the 8 core areas of neurologic disorders:

  • Dementia/Alzheimer Disease
  • Epilepsy
  • Headache/Migraine
  • Movement Disorders
  • Multiple Sclerosis
  • Neuromuscular Disorders
  • Stroke
  • Sleep Disorders

With many new options in practice and many more in development, it is essential for you and your colleagues to understand the current data and best practices as part of a multidisciplinary care team. This 1st Annual International Congress on the Future of Neurology™ is specifically designed for you, the practitioner, in mind. This 2-day educational program will help you integrate these new strategies into your clinical practice through data presentations, case-based discussions, and robust Q&A. The symposium will bring together world-renowned experts to discuss the impact of new evidence and novel agents in the treatment of neurologic disorders in a highly practical format.

Please join us in New York City for this new meeting—the first of its kind.

Acknowledgement of Commercial Support


This activity is supported by educational grants from Akcea Therapeutics; Alder BioPharmaceuticals, Inc.; Alnylam Pharmaceuticals, Inc.; Eisai; Jazz Pharmaceuticals, Inc.; Lilly; Mallinckrodt Pharmaceuticals; Mitsubishi Tanabe Pharma America, Inc.; Portola Pharmaceuticals, Inc.; Sarepta Therapeutics, Inc.; SK Life Science, Inc.; and Supernus Pharmaceuticals.

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Target Audience


This activity is directed toward physicians who treat patients with neurologic disorders. Fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals interested in the management of patients with neurologic disorders are also invited to participate.

Learning Objectives


Upon successful completion of this activity, you should be better prepared to:

  • Describe clinical strategies for diagnosing neurological disorders
  • Identify current strategies and recent advancements in the treatment and prevention of neurological disorders
  • Explain the mechanism of action of therapeutic agents used to treat neurological disorders
  • Recognize and devise strategies to manage treatment-related adverse events in the setting of neurological disorders
  • Outline multidisciplinary care and team communication strategies to optimize patient outcomes in the setting of neurological disorders
  • Discuss recent clinical trial data in the context of its potential impact on the management of neurological disorders

Program Chair


Stephen Silberstein, MD
Director
Professor of Neurology
Jefferson Headache Center
The Vickie and Jack Farber Institute for Neuroscience
Sidney Kimmel Medical College at Thomas Jefferson University
Philadelphia, PA